A central venous catheter self-management education program is an effective nursing intervention to promote long-term self-management of a CVC for discharged patients with cancer.
Daily chlorhexidine gluconate bathing on all patients with ports and tunneled catheters decreased the rates of CLABSI on an inpatient oncology unit.
Formation of a multidisciplinary team and a focus on evidence-based interventions successfully reduced the rate of central line bloodstream infections (CLABSI) on an inpatient oncology unit.
PICC Claiming Antithrombogenic, Antimicrobial Properties Failed to Reduce Thromboses, Line DysfunctionApril 30, 2016
A PICC with preclinical data claiming antithrombogenic and antimicrobial properties failed to reduce the rate of CLABSI or catheter-related thromboses compared with a standard PICC.
Simulation-based learning improved the confidence and skills of oncology nurses in chemotherapy-biotherapy administration.
An experimental therapy looks to hold promise for tumor control treatment in pancreatic adenocarcinoma.
A nurse-directed independent survey for patient feedback can inform measurable improvements in patient education and satisfaction survey scores.
The effectiveness of chemotherapy was enhanced by targeting survivin, a protein that inhibits apoptosis or cell death, according to preclinical research in cells and mouse models of retinoblastoma.
A small, phase I clinical trial indicates the experimental drug guadecitabine is safe in combination with the chemotherapy drug irinotecan, and it may overcome resistance to irinotecan in patients with metastatic colorectal cancer.
A previously unidentified avenue exists for potential therapies for peripheral neuropathy induced by the chemotherapeutic agent paclitaxel.
Anthracycline chemotherapy, such as doxorubicin and daunorubicin, is not associated with lasting cognitive decline among breast cancer survivors.
The addition of chemotherapy to radiation therapy prolonged survival in adults with grade 2 glial brain tumors.
A study examined the relation between various forms of breast cancer therapies and risk of congestive heart failure.
Adding aflibercept to first-line mFOLFOX6 did not improve progression-free survival compared with mFOLFOX6 alone in patients with mCRC, and the combination was associated with higher toxicity.
Progression-free and Overall Survival Better With Mutations Affecting DNA Repair Genes in Ovarian CancerApril 08, 2016
Women with advanced ovarian cancer who had mutations affecting DNA repair genes had longer progression-free and overall survival than women without the mutations.
German Study Confirms Accuracy of Multigene Test Predictions of Safe Omission of Chemotherapy for Breast CancerApril 07, 2016
A multigene test can identify patients with early stage breast cancer who do not need chemotherapy and who will be alive 5 years after diagnosis.
Anxiety and Depressive Symptoms Are Increased in Pediatric Survivors of Acute Lymphoblastic LeukemiaApril 04, 2016
Emotional distress during and after undergoing chemotherapy for ALL affects a significant percentage of children with the disease.
As summer approaches, many patients with CML who are taking oral chemotherapy drugs have questions about taking their drugs while traveling. What advice can we give them regarding this?
Disparities Related to Race, Insurance, and Facility Type Affect Use of Genetic Assay in Breast CancerApril 01, 2016
Use and clinical implications of a test commonly used to predict the aggressiveness of early stage ER-positive breast cancer is influenced by patient's race, insurance, and type of facility.
Neurofeedback Training Enables Cancer Survivors to Control Chemotherapy-Induced Peripheral NeuropathyApril 01, 2016
Chronic pain was decreased and quality of life was increased through neurofeedback.
Treatment with lapatinib and trastuzumab before surgery and chemotherapy led to significant shrinkage or disappearance of the tumors in approximately 25% of women with HER2-positive breast cancer.
Dose-dense adjuvant chemotherapy (every 2 weeks) offers improved survival without increasing the risk of treatment-induced early menopause compared with the standard interval (every 3 weeks) chemotherapy for premenopausal women with breast cancer.
Significant sensitivity to cisplatin-based chemotherapy is signaled by the presence of low expression of SMARCA4/BRG1 in patients with earlier-stage NSCLC. Low expression of SMARCA4/BRG1 was also linked to a poor prognosis.
A weekly dose of temsirolimus 75 mg was found to be active in patients with relapsed/refractory primary CNS lymphoma (PCNSL); however, only some patients achieved long-term control.
A next-generation immunotherapy may offer hope for treating high-grade glioma, an aggressive form of brain cancer that is notoriously hard to treat.
Adding panobinostat to radiotherapy appears safe, tolerable, and has preliminary efficacy for treating recurrent high-grade gliomas.
Adding Palbociclib to Fulvestrant Improves Progression-free Survival in Select Women With Metastatic Breast CancerMarch 22, 2016
Progression-free survival was significantly and consistently improved when palbociclib was added to fulvestrant, compared with placebo and fulvestrant, for women with stage IV breast cancer that is hormone-receptor-positive and HER2-negative.
An analysis of test results can help women who won't benefit from additional treatment avoid potential side effects.
Adding radiotherapy to chemotherapy and surgery reduced the number of local disease recurrences but did not affect distant recurrences or survival.
Combination therapy with durvalumab and tremelimumab demonstrated antitumor activity in 23% of 102 patients with lung cancer in a phase 1b trial, and toxicity was manageable.
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Navigator-specific Interventions and Multidisciplinary Care Team Collaboration Improves Care and Outcomes for Patients with GI Cancers
- Antibody Therapy Reduces Numbers of Cancer Stem Cells in Patients With Multiple Myeloma
- Diet Can Affect Aggressiveness of Prostate Cancer
- Research Identifies Underlying Mechanism of Chemotherapy-Induced Peripheral Neuropathy
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Acupuncture Improves Management of Hot Flashes, Quality of Life in Breast Cancer
- Higher Vitamin D Levels Lower Risk of Cancer in Women
- Getting Started: Implementation of an Oncology Navigation Program That Meets Community Needs
- Beyond Treatment: Anticipating the Late Effects of Cancer Treatment in Survivors
- Central Venous Catheter Self-management Education Program Effective
- Innovations Reduce Catheter Associated Urinary Tract Infection Rates at an Oncology Hospital
- Daily Chlorhexidine Gluconate Bathing Reduces CLABSI Rates
- Hygiene Practice Interventions Reduced CLABSI on an Inpatient Oncology Unit
- PICC Claiming Antithrombogenic, Antimicrobial Properties Failed to Reduce Thromboses, Line Dysfunction
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|